09-R355

2009 -- S 1068

Enacted 10/29/09

 

 

S E N A T E R E S O L U T I O N

RESPECTFULLY REQUESTING MERCK & CO., INC. TO IMMEDIATELY RESUME PRODUCTION OF THE MONOVALENT VACCINES FOR MEASLES, MUMPS, AND RUBELLA

     

     

     Introduced By: Senators Blais, Perry, and Miller

     Date Introduced: October 29, 2009

 

     

 

 

     WHEREAS, A vaccine is a biological preparation designed to improve immunity to a

particular disease. Throughout the last two centuries, the benefits of vaccinations in preventing

illness, disability, and death are well-documented and indisputable; and  

     WHEREAS, Monovalent vaccines are formulated to immunize against a single antigen or

single microorganism, while the MMR vaccine is a combined live virus vaccine for vaccination

against measles (rubeola), mumps, and rubella (German measles); and  

     WHEREAS, Merck & Co., Inc. has prioritized the production of the combined M-M-R II

vaccine and suspended production of the monovalent vaccines for measles, mumps, and rubella

for at least the next two years, rendering the monovalent vaccines unavailable for order or

distribution; and  

     WHEREAS, Over the past decade, parental concerns over the possible correlation

between autism and administering the combined MMR vaccine have arisen. Although research

has not found a relationship between the MMR vaccine and autism, many parents still question

whether the experts are right, due in part to the fact that the signs of autism tend to appear around

the time children receive the combined MMR vaccine; and  

     WHEREAS, In these specific situations, the use of monovalent vaccines for measles,

mumps, and rubella is an alternative that allays parentsí uncertainties while still protecting their

children; now, therefore be it  

     RESOLVED, That this Senate of the State of Rhode Island and Providence Plantations

hereby respectfully requests Merck & Co., Inc. to immediately resume production of the

monovalent vaccines for measles, mumps, and rubella; and be it further 

     RESOLVED, That the Secretary of State be and he hereby is authorized and directed to

transmit a duly certified copy of this resolution to Mr. Craig Kemp, Senior Director of Customer

Feedback and Response, Merck & Co., Inc.

     

=======

LC02965

=======